Bionano Genomics Inc. [NASDAQ: BNGO] gained 2.36% on the last trading session, reaching $1.30 price per share at the time. The company report on February 27, 2023 that Bionano to Present at the 43rd Annual Cowen Healthcare Conference.
A live webcast of the presentation will be available to view on the Events page in the Investors section of Bionano’s website.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Bionano Genomics Inc. represents 296.92 million in outstanding shares, while the company has a total market value of $413.33 million with the latest information. BNGO stock price has been found in the range of $1.28 to $1.33.
If compared to the average trading volume of 7.23M shares, BNGO reached a trading volume of 6457868 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Bionano Genomics Inc. [BNGO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BNGO shares is $5.65 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BNGO stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Scotiabank have made an estimate for Bionano Genomics Inc. shares, keeping their opinion on the stock as Sector Outperform, with their previous recommendation back on January 05, 2023. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on December 12, 2022, representing the official price target for Bionano Genomics Inc. stock. Previously, the target price had yet another raise to $12, while Oppenheimer analysts kept a Outperform rating on BNGO stock.
The Average True Range (ATR) for Bionano Genomics Inc. is set at 0.11, with the Price to Sales ratio for BNGO stock in the period of the last 12 months amounting to 15.96. The Price to Book ratio for the last quarter was 1.34, with the Price to Cash per share for the same quarter was set at 0.57.
Trading performance analysis for BNGO stock
Bionano Genomics Inc. [BNGO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.33. With this latest performance, BNGO shares dropped by -28.18% in over the last four-week period, additionally sinking by -54.55% over the last 6 months – not to mention a drop of -38.39% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BNGO stock in for the last two-week period is set at 32.46, with the RSI for the last a single of trading hit 27.66, and the three-weeks RSI is set at 36.16 for Bionano Genomics Inc. [BNGO]. The present Moving Average for the last 50 days of trading for this stock 1.6533, while it was recorded at 1.3460 for the last single week of trading, and 1.9502 for the last 200 days.
Bionano Genomics Inc. [BNGO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Bionano Genomics Inc. [BNGO] shares currently have an operating margin of -428.79 and a Gross Margin at +4.47. Bionano Genomics Inc.’s Net Margin is presently recorded at -402.84.
Return on Equity for this stock declined to -38.92, with Return on Assets sitting at -33.11.
Bionano Genomics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.80 and a Current Ratio set at 6.50.
An analysis of insider ownership at Bionano Genomics Inc. [BNGO]
There are presently around $108 million, or 27.30% of BNGO stock, in the hands of institutional investors. The top three institutional holders of BNGO stocks are: BLACKROCK INC. with ownership of 23,240,256, which is approximately 7.507% of the company’s market cap and around 1.87% of the total institutional ownership; VANGUARD GROUP INC, holding 16,064,444 shares of the stock with an approximate value of $20.88 million in BNGO stocks shares; and STATE STREET CORP, currently with $13.55 million in BNGO stock with ownership of nearly 9.938% of the company’s market capitalization.
Positions in Bionano Genomics Inc. stocks held by institutional investors increased at the end of Thursday and at the time of the Thursday reporting period, where 87 institutional holders increased their position in Bionano Genomics Inc. [NASDAQ:BNGO] by around 7,402,411 shares. Additionally, 58 investors decreased positions by around 4,615,333 shares, while 34 investors held positions by with 70,727,314 shares. The mentioned changes placed institutional holdings at 82,745,058 shares, according to the latest SEC report filing. BNGO stock had 29 new institutional investments in for a total of 576,825 shares, while 24 institutional investors sold positions of 2,517,721 shares during the same period.